Table 1 Summary of patient characteristics and tumor measurements
Baseline demographics and disease characteristics | ||
|---|---|---|
Gender | Male | 14 (66.7) |
Female | 7 (33.3) | |
Age (years) | Median [Range] | 53 [25-68] |
Tumor stage | IV | 20 (95.2) |
III Unresectable | 1 (4.8) | |
Doses of agents | Ipi: 10 mg/kg, Bev: 15 mg/kg | 8 (38.1) |
Ipi: 10 mg/kg, Bev: 7.5 mg/kg | 5 (23.8) | |
Ipi: 3 mg/kg, Bev: 15 mg/kg | 2 (9.5) | |
Ipi: 3 mg/kg, Bev: 7.5 mg/kg | 6 (28.6) | |
Baseline sum diameter (mm) | Median [Range] | 38 [10-178] |
Mean [SD] | 55.1 [43.9] | |
Baseline average density (HU) | Median [Range] | 43.2 [8.0-69.2] |
Mean [SD] | 43.4 [16.2] | |
Changes from the baseline measurements | ||
Absolute diameter change at 1 st follow-up (mm) | Median [Range] | 0 [-21.0 - 56] |
Mean [SD] | 5.5 [18.0] | |
Proportional diameter change at 1 st follow-up (%) | Median [Range] | 0 [-64.7 - 85.7] |
Mean [SD] | 3.6 [34.4] | |
Absolute density change at 1 st follow-up (HU) | Median [Range] | -4.3 [-24.3 - 18.5] |
Mean [SD] | -3.1 [10.8] | |
Proportional density change at 1 st follow-up (%) | Median [Range] | -8.4 [-44.3 - 49.1] |
Mean [SD] | -3.1 [24.5] | |